MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    The effect of exercise on pain in Parkinson’s disease: a systematic review

    V. Nguy, F. Pourkazemi, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)

    Objective: To perform a systematic review assessing the effects of exercise on pain in people with Parkinson’s disease (PD) (PROSPERO registration CRD42019129154). Background: Chronic pain…
  • MDS Virtual Congress 2021

    THE SEVERITY OF MOTOR SYMPTOMS IS A RISK FACTOR FOR SEBORRHEIC DERMATITIS IN PARKINSON’S DISEASE PATIENTS

    I. Kuric, T. Gilman Kuric, Z. Popovic, J. Kragujevic, T. Mirosevic Zubonja, I. Rajkovaca, S. Matosa, S. Tomic ()

    Objective: The aim was to determine correlation and difference according to severity of SD with motor and nonmotor symptoms, age, gender and levodopa equivalent daily…
  • MDS Virtual Congress 2021

    Sphingosine-1-phosphate, motor severity and progression in Parkinson’s disease (MARK-PD)

    C. Choe, C. Englisch, L. Niemann, S. Lezius, M. von Lucadou, K. Marmann, R. Böger, S. Peine, G. Daum, C. Gerloff, E. Schwedhelm (Hamburg, Germany)

    Objective: We assessed the association of serum sphingosine-1-phosphate (S1P) levels with motor and cognitive symptoms in patients with Parkinson’s disease (PD). Background: Treatment with sphingosine-1-phosphate…
  • MDS Virtual Congress 2021

    Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study

    P. Zhang, P. Huang, Y. Qian, X. Yang, Y. He, J. Du, G. Li, S. Cui, S. Xu, J. Liu, Y. Lin, Y. Fu, G. He, Z. Zhang, Q. Xiao, S. Chen (Shanghai, China)

    Objective: To investigate the difference in the gut microbiota between drug-naïve and medicated PD patients and focus on the association between gut microbiota and anti-PD medications. Background:…
  • MDS Virtual Congress 2021

    Implementing a community-based Parkinson’s Disease Wellness Program during COVID

    A. Boddy, M. Lomaglio (Waco, USA)

    Objective: The objective is to present a successful and safe community-based Parkinson’s Disease program during a worldwide pandemic. Background: The COVID-19 pandemic shut down most…
  • MDS Virtual Congress 2021

    iFall: Co-producing an instrumented application prototype for falls reporting in Parkinson’s disease

    R. Morris, E. Webster, G. Standerline, J. Moore, A. Godfrey, A. Amjad (Newcastle Upon Tyne, United Kingdom)

    Objective: To work with those affected by Parkinson’s disease (PD) to co-produce a prototype of an instrumented application for reporting falls (iFall). Background: Falls commonly…
  • MDS Virtual Congress 2021

    Development of a remote physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease

    C. Torriani-Pasin, T. Freitas, V. Domingues, B. Araújo, G. Palma, M. Makhoul, R. Andreotti, L. Mochizuki (Sao Paulo, Brazil)

    Objective: To describe the development process of adaptation of in-person physical exercise program to telemonitoring format to people with Parkinson’s disease (PD). Background: People with…
  • MDS Virtual Congress 2021

    Life Satisfaction and Adaptation in Persons with Parkinson’s Disease

    L. Rosengren, A. Forsberg, C. Brogardh, J. Lexell (Lund, Sweden)

    Objective: This study aimed to gain an in-depth understanding of the meaning of LS and adaptation in persons with PD. Background: Persons with Parkinson’s disease…
  • MDS Virtual Congress 2021

    Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)

    M. Tosin, C. Goetz, G. Stebbins, B. Oliveira (Niteroi, Brazil)

    Objective: To implement the first 3 phases of the scale development process that will create the PD-MAS. Background: Drug therapy is a central strategy in…
  • MDS Virtual Congress 2021

    Anodic stimulation reduces corticospinal tract engagement in STN-DBS for Parkinson’s disease: a case report.

    G. Di Rauso, S. Coniglio, A E. Vaudano, F. Cavallieri, A. Puzzolante, A. Feletti, F. Antonelli, S. Meletti, F. Valzania, V. Rispoli (Modena, Italy)

    Objective: To seek how novel programming options modify the therapeutic window in a case of off-targeting DBS. Background: In Parkinson’s disease deep brain stimulation (DBS)…
  • « Previous Page
  • 1
  • …
  • 429
  • 430
  • 431
  • 432
  • 433
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24475 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley